in

LORDVIQUA 100 mg Film-Coated Tablet



Lively Ingredient: Lorlatinib Pharmaceutical Model Identify: LORVIQUA 100 mg Film-Coated Tablets LORVIQUA 100 mg respectively; It’s labeled as Antineoplastic and Immunomodulatory Brokers, Antineoplastics, Different Antineoplastics, Protein kinase inhibitors and Lorlatinib and is among the many licensed medication within the Medicines and Medical Gadgets Company with the ATC code L01ED05. LORVİQUA 100 mg, which you’ll be able to receive from the pharmacy with a standard prescription, is a product of PFİZER PFE İLAÇLARI. Transient data and leaflet paperwork for LORBRENA 100 mg (Indications, what’s LORBRENA what drug it’s; what to observe earlier than beginning the drug, whether or not its use is appropriate for breastfeeding or pregnant girls; interplay, drawbacks; advantages, storage circumstances; utilization technique; LORDVIQUA dosage; negative effects, negative effects, corresponding to actions and suggestions
The submit LORDVIQUA 100 mg Film-Coated Tablet first appeared on İlaç Internet.

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.

You May Also Like:  KOLISTATE 150 mg vial containing lyophilized powder for IM/IV injection and inhalation

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

LORVIQUA 25 mg Film-Coated Tablet, what it is, what it does, side effects, how to use

RIVOCLON 2.5 mg/1 ml Oral Drops